Docetaxel in very elderly men with metastatic castration-resistant prostate cancer

PURPOSE: To evaluate the use of docetaxel in very elderly men with metastatic castration-resistant prostate cancer (mCRPC) treated in routine clinical care. METHODS: A retrospective case series of men with mCRPC aged ≥80 years and treated with docetaxel between July 2006 and June 2012 at three commu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Prostate Int
Prif Awduron: Wong, Hui-Li, Lok, Sheau Wen, Wong, Shirley, Parente, Phillip, Rosenthal, Mark
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Asian Pacific Prostate Society 2015
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494632/
https://ncbi.nlm.nih.gov/pubmed/26157766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2015.03.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg